Anna Sadowska

Anna Sadowska

Auto-generated profile, based on publicly available information

Anna Sadowska

Department of Transplantation Medicine and Nephrology, Medical University of Warsaw, Warsaw, Poland

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 April 2018 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
DDDominika Deborska-Materkowska
Dominika Deborska-Materkowska
APAgnieszka Perkowska-Ptasinska
Agnieszka Perkowska-Ptasinska
ASAnna Sadowska
Anna Sadowska
JGJolanta Gozdowska
Jolanta Gozdowska
MCMichał Ciszek
Michał Ciszek
MDMagdalena Durlik
Magdalena Durlik
Despite universal prophylaxis, late cytomegalovirus (CMV) infection occurs in a high proportion of kidney transplant recipients. We evaluated whether a specific viral T-cell response allows for the better identification of recipients who are at high risk of CMV infection after prophylaxis withdrawal. We conducted a prospective study in 19 pretransplant anti-CMV seronegative kidney graft recipients R- (18 from seropositive donors [D+] and one from a seronegative donor [D-]) and 67 seropositive recipients R(+) (59 from seropositive donors and eight from seronegative donors) who received antiviral prophylaxis with valganciclovir. The QuantiFERON-CMV (QF-CMV) assay was performed within the first and third months after transplantation. Blood samples were monitored for CMV DNAemia using a commercial quantitative nucleic acid amplification test (QNAT) that was calibrated to the World Health Organization International Standard. Twenty-one of the 86 patients (24%) developed CMV viremia after prophylaxis withdrawal within 12 months posttransplantation. In the CMV R(+) group, the QF-CMV assay yielded reactive results (QF-CMV[+]) in 51 of 67 patients (76%) compared with 7 of 19 patients (37%) in the CMV R(−) group (p = 0.001). In the CMV R(+) group, infection occurred in seven of 16 recipients (44%) who were QF-CMV(−) and eight of 51 recipients (16%) who were QF-CMV(+). In the CMV R(−) group, infection evolved in five of 12 recipients (42%) who were QF-CMV(−) and one of 7 recipients (14%) who were QF-CMV(+). No difference was found in the incidence of CMV infection stratified according to the QF-CMV results with regard to the recipients’ pretransplant CMV IgG serology (p = 0.985). Cytomegalovirus infection occurred in 15 of 36 patients (42%) with hypogammaglobulinemia (HGG) 90 days posttransplantation compared with two of 34 patients (6%) without HGG (p = 0.0004). Cytomegalovirus infection occurred in seven of 13 patients (54%) with lymphocytopenia compared with 14 of 70 patients (20%) without lymphocytopenia (p = 0.015). The multivariate analysis revealed that the nonreactive QuantiFERON-CMV assay was an independent risk factor for postprophylaxis CMV infection. In kidney transplant recipients who received posttransplantation prophylaxis, negative QF-CMV results better defined the risk of CMV infection than initial CMV IgG status after prophylaxis withdrawal. Hypogammaglobulinemia and lymphocytopenia were risk factors for CMV infection.

1 March 2005 in Transplantation Proceedings
Verified
Journal Article
Closed access
TBTeresa Bączkowska
Teresa Bączkowska
APA. Perkowska-Ptasińska
A. Perkowska-Ptasińska
ASA. Sadowska
A. Sadowska
ZLZ. Lewandowski
Z. Lewandowski
ENE. Nowacka-Cieciura
E. Nowacka-Cieciura
RDR. Danielewicz
R. Danielewicz

1 January 2006 in Transplantation Proceedings
Verified
Journal Article
Closed access
DDDominika Deborska-Materkowska
Dominika Deborska-Materkowska
ZLZ. Lewandowski
Z. Lewandowski
ASA. Sadowska
A. Sadowska
ENE. Nowacka-Cieciura
E. Nowacka-Cieciura
WCWitold Chudziński
Witold Chudziński
MDMagdalena Durlik
Magdalena Durlik

1 May 2013 in Transplantation Proceedings
Verified
Journal Article
Closed access
AFAgnieszka Furmańczyk-Zawiska
Agnieszka Furmańczyk-Zawiska
TBTeresa Bączkowska
Teresa Bączkowska
ASA. Sadowska
A. Sadowska
JSJ. Szmidt
J. Szmidt
ACA. Chmura
A. Chmura
MDMagdalena Durlik
Magdalena Durlik

1 June 2016 in Transplantation Proceedings
Verified
Journal Article
Closed access
JPJ. Pazik
J. Pazik
ZLZ. Lewandowski
Z. Lewandowski
MOMonika Oldak
Monika Oldak
DODominika Oziębło
Dominika Oziębło
APA. Perkowska Ptasinska
A. Perkowska Ptasinska
MDMagdalena Durlik
Magdalena Durlik

1 October 2014 in Transplantation Proceedings
Verified
Journal Article
Closed access
JGJolanta Gozdowska
Jolanta Gozdowska
AUA. Urbanowicz
A. Urbanowicz
ASA. Sadowska
A. Sadowska
MBM. Bieniasz
M. Bieniasz
Michal WszolaMichal Wszola
Michal Wszola
MDMagdalena Durlik
Magdalena Durlik